市場調査レポート
商品コード
1087341

プロテアソーム阻害剤の世界市場:2022年~2026年

Global Proteasome Inhibitors Market 2022-2026

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
プロテアソーム阻害剤の世界市場:2022年~2026年
出版日: 2022年05月29日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のプロテアソーム阻害剤の市場規模は、2022年~2026年の間に22億米ドルの増加が見込まれ、予測期間中に7.4%のCAGRで緩やかに成長すると予測されています。

膨大なアンメットニーズ、採用率の高さ、多発性骨髄腫の発生率の上昇が、市場を牽引しています。

当レポートでは、世界のプロテアソーム阻害剤市場について調査分析し、全体的な分析、市場規模と予測、動向、成長促進要因、課題、および約25社のベンダーをカバーするベンダー分析を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場のエコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模(2021年)
  • 市場の見通し:2021年~2026年の予測

第4章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • ライバルの脅威
  • 市況

第5章 製品別の市場セグメンテーション

  • 市場セグメント
  • 製品別の比較
  • ベルケイド:市場規模と予測(2021年~2026年)
  • カイプロリス:市場規模と予測(2021年~2026年)
  • ニンラーロ:市場規模と予測(2021年~2026年)
  • その他:市場規模と予測(2021年~2026年)
  • 製品別の市場機会

愛6章 顧客情勢

  • 顧客情勢の概要

第7章 地域別の情勢

  • 地域別のセグメンテーション
  • 地域別の比較
  • 北米:市場規模と予測(2021年~2026年)
  • 欧州:市場規模と予測(2021年~2026年)
  • アジア:市場規模と予測(2021年~2026年)
  • その他の地域(ROW):市場規模と予測(2021年~2026年)
  • 米国:市場規模と予測(2021年~2026年)
  • 英国:市場規模と予測(2021年~2026年)
  • ドイツ:市場規模と予測(2021年~2026年)
  • カナダ:市場規模と予測(2021年~2026年)
  • フランス:市場規模と予測(2021年~2026年)
  • 地域情勢別の市場機会

第8章 促進要因・課題・動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第9章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱情勢
  • 業界のリスク

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • AbbVie Inc.
  • Accuitis Inc.
  • Amgen Inc.
  • Bristol Myers Squibb Co.
  • Cantex Pharmaceuticals Inc.
  • Fresenius SE and Co. KGaA
  • Johnson and Johnson
  • Takeda Pharmaceutical Co. Ltd.
  • TG Therapeutics Inc.

第11章 付録

目次
Product Code: IRTNTR73564

Technavio has been monitoring the proteasome inhibitors market and it is poised to grow by $ 2.20 bn during 2022-2026, decelerating at a CAGR of 7.4% during the forecast period. Our report on the proteasome inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by huge unmet need, strong adoption rate, and growing incidence of multiple myeloma.

The proteasome inhibitors market analysis includes the product segment and geographic landscape.

Technavio's proteasome inhibitors market is segmented as below:

By Product

  • VELCADE
  • KYPROLIS
  • NINLARO
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the expanded application as one of the prime reasons driving the proteasome inhibitors market growth during the next few years. Also, special drug designations and rapid growth potential in developing economies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on proteasome inhibitors market covers the following areas:

  • Proteasome inhibitors market sizing
  • Proteasome inhibitors market forecast
  • Proteasome inhibitors market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading proteasome inhibitors market vendors that include AbbVie Inc., Accuitis Inc., Amgen Inc., Bristol Myers Squibb Co., Cantex Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Johnson and Johnson, Takeda Pharmaceutical Co. Ltd., and TG Therapeutics Inc. Also, the proteasome inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments
  • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
  • 5.2 Comparison by Product
  • Exhibit 26: Chart on Comparison by Product
  • Exhibit 27: Data Table on Comparison by Product
  • 5.3 VELCADE - Market size and forecast 2021-2026
  • Exhibit 28: Chart on VELCADE - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on VELCADE - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on VELCADE - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on VELCADE - Year-over-year growth 2021-2026 (%)
  • 5.4 KYPROLIS - Market size and forecast 2021-2026
  • Exhibit 32: Chart on KYPROLIS - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on KYPROLIS - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on KYPROLIS - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on KYPROLIS - Year-over-year growth 2021-2026 (%)
  • 5.5 NINLARO - Market size and forecast 2021-2026
  • Exhibit 36: Chart on NINLARO - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on NINLARO - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on NINLARO - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on NINLARO - Year-over-year growth 2021-2026 (%)
  • 5.6 Others - Market size and forecast 2021-2026
  • Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.7 Market opportunity by Product
  • Exhibit 44: Market opportunity by Product ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 48: Chart on Geographic comparison
  • Exhibit 49: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.9 Germany - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.10 Canada - Market size and forecast 2021-2026
  • Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.11 France - Market size and forecast 2021-2026
  • Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 89: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 90: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 91: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 92: Matrix on vendor position and classification
  • 10.3 AbbVie Inc.
  • Exhibit 93: AbbVie Inc. - Overview
  • Exhibit 94: AbbVie Inc. - Product / Service
  • Exhibit 95: AbbVie Inc. - Key offerings
  • 10.4 Accuitis Inc.
  • Exhibit 96: Accuitis Inc. - Overview
  • Exhibit 97: Accuitis Inc. - Product / Service
  • Exhibit 98: Accuitis Inc. - Key offerings
  • 10.5 Amgen Inc.
  • Exhibit 99: Amgen Inc. - Overview
  • Exhibit 100: Amgen Inc. - Product / Service
  • Exhibit 101: Amgen Inc. - Key offerings
  • 10.6 Bristol Myers Squibb Co.
  • Exhibit 102: Bristol Myers Squibb Co. - Overview
  • Exhibit 103: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 104: Bristol Myers Squibb Co. - Key offerings
  • 10.7 Cantex Pharmaceuticals Inc.
  • Exhibit 105: Cantex Pharmaceuticals Inc. - Overview
  • Exhibit 106: Cantex Pharmaceuticals Inc. - Product / Service
  • Exhibit 107: Cantex Pharmaceuticals Inc. - Key news
  • Exhibit 108: Cantex Pharmaceuticals Inc. - Key offerings
  • 10.8 Fresenius SE and Co. KGaA
  • Exhibit 109: Fresenius SE and Co. KGaA - Overview
  • Exhibit 110: Fresenius SE and Co. KGaA - Business segments
  • Exhibit 111: Fresenius SE and Co. KGaA - Key news
  • Exhibit 112: Fresenius SE and Co. KGaA - Key offerings
  • Exhibit 113: Fresenius SE and Co. KGaA - Segment focus
  • 10.9 Johnson and Johnson
  • Exhibit 114: Johnson and Johnson - Overview
  • Exhibit 115: Johnson and Johnson - Business segments
  • Exhibit 116: Johnson and Johnson - Key news
  • Exhibit 117: Johnson and Johnson - Key offerings
  • Exhibit 118: Johnson and Johnson - Segment focus
  • 10.10 Takeda Pharmaceutical Co. Ltd.
  • Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • 10.11 TG Therapeutics Inc.
  • Exhibit 123: TG Therapeutics Inc. - Overview
  • Exhibit 124: TG Therapeutics Inc. - Product / Service
  • Exhibit 125: TG Therapeutics Inc. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 126: Inclusions checklist
  • Exhibit 127: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 128: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 129: Research methodology
  • Exhibit 130: Validation techniques employed for market sizing
  • Exhibit 131: Information sources
  • 11.5 List of abbreviations
  • Exhibit 132: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Product - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Product - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Product
  • Exhibits27: Data Table on Comparison by Product
  • Exhibits28: Chart on VELCADE - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on VELCADE - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on VELCADE - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on VELCADE - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on KYPROLIS - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on KYPROLIS - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on KYPROLIS - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on KYPROLIS - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on NINLARO - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on NINLARO - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on NINLARO - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on NINLARO - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits44: Market opportunity by Product ($ million)
  • Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits48: Chart on Geographic comparison
  • Exhibits49: Data Table on Geographic comparison
  • Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits83: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits84: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibits85: Data Table on France - Year-over-year growth 2021-2026 (%)
  • Exhibits86: Market opportunity By Geographical Landscape ($ million)
  • Exhibits87: Impact of drivers and challenges in 2021 and 2026
  • Exhibits88: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits89: Overview on factors of disruption
  • Exhibits90: Impact of key risks on business
  • Exhibits91: Vendors covered
  • Exhibits92: Matrix on vendor position and classification
  • Exhibits93: AbbVie Inc. - Overview
  • Exhibits94: AbbVie Inc. - Product / Service
  • Exhibits95: AbbVie Inc. - Key offerings
  • Exhibits96: Accuitis Inc. - Overview
  • Exhibits97: Accuitis Inc. - Product / Service
  • Exhibits98: Accuitis Inc. - Key offerings
  • Exhibits99: Amgen Inc. - Overview
  • Exhibits100: Amgen Inc. - Product / Service
  • Exhibits101: Amgen Inc. - Key offerings
  • Exhibits102: Bristol Myers Squibb Co. - Overview
  • Exhibits103: Bristol Myers Squibb Co. - Product / Service
  • Exhibits104: Bristol Myers Squibb Co. - Key offerings
  • Exhibits105: Cantex Pharmaceuticals Inc. - Overview
  • Exhibits106: Cantex Pharmaceuticals Inc. - Product / Service
  • Exhibits107: Cantex Pharmaceuticals Inc. - Key news
  • Exhibits108: Cantex Pharmaceuticals Inc. - Key offerings
  • Exhibits109: Fresenius SE and Co. KGaA - Overview
  • Exhibits110: Fresenius SE and Co. KGaA - Business segments
  • Exhibits111: Fresenius SE and Co. KGaA - Key news
  • Exhibits112: Fresenius SE and Co. KGaA - Key offerings
  • Exhibits113: Fresenius SE and Co. KGaA - Segment focus
  • Exhibits114: Johnson and Johnson - Overview
  • Exhibits115: Johnson and Johnson - Business segments
  • Exhibits116: Johnson and Johnson - Key news
  • Exhibits117: Johnson and Johnson - Key offerings
  • Exhibits118: Johnson and Johnson - Segment focus
  • Exhibits119: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits120: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits121: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits122: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits123: TG Therapeutics Inc. - Overview
  • Exhibits124: TG Therapeutics Inc. - Product / Service
  • Exhibits125: TG Therapeutics Inc. - Key offerings
  • Exhibits126: Inclusions checklist
  • Exhibits127: Exclusions checklist
  • Exhibits128: Currency conversion rates for US$
  • Exhibits129: Research methodology
  • Exhibits130: Validation techniques employed for market sizing
  • Exhibits131: Information sources
  • Exhibits132: List of abbreviations